TrialTrials2016

Mirtazapine added to selective serotonin reuptake inhibitors for treatment-resistant depression in primary care (MIR trial): study protocol for a randomised controlled trial.

Debbie Tallon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.